{
    "root": "30142b39-1441-7d9f-e063-6394a90ac169",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CIPROFLOXACIN HYDROCHLORIDE",
    "value": "20250311",
    "ingredients": [
        {
            "name": "ACETIC ACID",
            "code": "Q40Q9N063P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15366"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13404"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "SODIUM ACETATE",
            "code": "4550K0SC9B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32954"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "BENZALKONIUM CHLORIDE",
            "code": "F5UM2KM3W7",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3020"
        },
        {
            "name": "CIPROFLOXACIN HYDROCHLORIDE",
            "code": "4BA73M5E37",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        }
    ],
    "indications": {
        "text": "ciprofloxacin ophthalmic solution indicated treatment infections caused susceptible strains designated microorganisms conditions listed : corneal ulcers : pseudomonas aeruginosa serratia marcescens * staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae streptococcus ( viridans group ) * conjunctivitis : haemophilus influenzae staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae * efficacy organism studied fewer 10 infections .",
        "doid_entities": [
            {
                "text": "conjunctivitis (DOID:6195)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6195"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "corneal ulcers : recommended regimen treatment corneal ulcersis two drops affected eye every 15 minutes first six hours two drops affected eye every 30 minutes remainder first day . second day , instill two drops affected eye hourly . third fourteenth day , place two drops affected eye every four hours . treatment may continued 14 days corneal re-epithelialization occurred . bacterial conjunctivitis : recommended regimen treatment bacterial conjunctivitisis one two drops instilled conjunctival sac ( ) every two hours awake two days one two drops every four hours awake next five days .",
        "doid_entities": [
            {
                "text": "bacterial conjunctivitis (DOID:9700)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9700"
            },
            {
                "text": "conjunctivitis (DOID:6195)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6195"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "supplied : sterile ophthalmic solution : 2.5 ml , 5 ml 10 ml translucent ldpe bottle , translucent ldpe nozzle tan coloured polypropylene closure . 2.5 ml - ndc 72888-102-21 5 ml - ndc 72888-102-22 10 ml - ndc 72888-102-23 storage : store 2\u00b0c 25\u00b0c ( 36\u00b0f 77\u00b0f ) . protect light .",
    "adverseReactions": "history hypersensitivity ciprofloxacin component medication contraindication . history hypersensitivity quinolones may also contraindicate ciprofloxacin .",
    "indications_original": "Ciprofloxacin ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below:\n                  \n                  \n                     Corneal Ulcers:\n                     \u00a0\u00a0\u00a0\u00a0Pseudomonas aeruginosa\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Serratia marcescens*\n\n \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Staphylococcus aureus\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Staphylococcus epidermidis\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Streptococcus pneumoniae\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Streptococcus(Viridans Group) *\n\n \n                  \n                     Conjunctivitis:\u00a0\u00a0\u00a0\n                     \u00a0\u00a0Haemophilus influenzae\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Staphylococcus aureus\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Staphylococcus epidermidis\n                  \n                  \n                     \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Streptococcus pneumoniae\n                  \n                  *Efficacy for this organism was studied in fewer than 10 infections.",
    "contraindications_original": "Corneal Ulcers:The recommended dosage regimen for the treatment of\n \n  corneal ulcersis two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelialization has not occurred.\n\n \n                  \n                  \n                     Bacterial Conjunctivitis:The recommended dosage regimen for the treatment of\n \n  bacterial conjunctivitisis one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days.",
    "warningsAndPrecautions_original": "How Supplied:As a sterile ophthalmic solution: 2.5 mL, 5 mL and 10 mL in translucent LDPE bottle, translucent LDPE nozzle and tan coloured polypropylene closure.\n\n \n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02.5 mL - NDC 72888-102-21\n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a05 mL - NDC 72888-102-22\n                  \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a010 mL - NDC 72888-102-23\n                  \n                     STORAGE:Store at 2\u00b0C to 25\u00b0C (36\u00b0F to 77\u00b0F). Protect from light.",
    "adverseReactions_original": "A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.",
    "drug": [
        {
            "name": "CIPROFLOXACIN HYDROCHLORIDE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        }
    ]
}